Home › SEC Filings › Insider Cluster Activity
Insider Cluster Activity
All Current Report (8-K)Annual Report (10-K)Quarterly Report (10-Q)Form 4 Insider TradesSC 13D Beneficial Ownership13F Institutional HoldingsPress ReleasesInsider Cluster ActivityInsider Buy Activity
Theme?
All themes Artificial IntelligenceSemiconductorsQuantum ComputingSpace & SatellitesRobotics & AutomationElectric VehiclesClean & Renewable EnergyBattery & Energy StorageNuclear & FusionCybersecurityCloud & SaaSFintech & PaymentsCrypto & BlockchainGenomics & Gene EditingBiotech & Drug DiscoveryE-commerce & PlatformsStreaming & Digital MediaGaming & EsportsDefense TechCannabis
| Ticker | Type | Sentiment | Impact | Summary | Date |
|---|---|---|---|---|---|
| ABEO | CLUSTER | neutral | 2/10 | Two insiders at Abeona Therapeutics (ABEO), the Chief Commercial Officer and SVP/Chief Legal Officer, conducted open-mar | Jul 9, 2026 |
| IONS | CLUSTER | neutral | 2/10 | Three IONIS insiders (two directors and an EVP) sold a total of ~$902K in open-market transactions over a one-week perio | Jul 9, 2026 |
| IMNM | CLUSTER | neutral | 4/10 | Three Immunome insiders sold a total of ~$813K in open-market shares over a one-week window ending July 7, 2026, includi | Jul 9, 2026 |
| SION | CLUSTER | bearish | 5/10 | Three Sionna insiders sold a combined $9.57M in open-market sales over a 7-day window, including a director ($5.27M) and | Jul 9, 2026 |
| NUVL | CLUSTER | neutral | 3/10 | Three top executives at Nuvalent (CEO, CFO, CDO) sold a combined $7.97M in open-market sales over a 7-day window, with t | Jul 9, 2026 |
| CADL | CLUSTER | neutral | 3/10 | Two C-suite insiders at Candel Therapeutics sold $306K in open-market sales on June 29, 2026, while a third insider rece | Jul 9, 2026 |
| RLAY | CLUSTER | neutral | 2/10 | Two insiders at Relay Therapeutics sold a combined $1.12M in stock over a one-week window, including a $955K sale by Pet | Jul 9, 2026 |
| MIRM | CLUSTER | neutral | 2/10 | Two Mirum Pharmaceuticals insiders (CFO Eric Bjerklholt and SVP/Global Controller Jolanda Howe) sold a combined $707K in | Jul 9, 2026 |
| UTHR | CLUSTER | neutral | 2/10 | CEO Martine Rothblatt sold ~$10.4M in open-market shares over two days (0.04% of market cap), alongside derivative exerc | Jul 9, 2026 |
| PTCT | CLUSTER | neutral | 2/10 | Two C-suite insiders (CTOO and EVP/CLO) sold a total of ~$2.6M in shares on July 6-7, 2026, predominantly tied to option | Jul 9, 2026 |
| PBYI | CLUSTER | neutral | 2/10 | Two PBYI insiders, including the CFO, sold a combined $147K in open-market sales over a 7-day window. The total value is | Jul 8, 2026 |
| BOLD | CLUSTER | neutral | 4/10 | Three 10% owners at Boundless Bio traded in opposing directions within a 7-day window: Kevin Tang (10% owner) purchased | Jul 8, 2026 |
| CORT | CLUSTER | neutral | 3/10 | Two Corcept insiders sold shares totaling ~$2.77M over a 7-day window, with the Chief Development Officer selling after | Jul 8, 2026 |
| XNCR | CLUSTER | neutral | 2/10 | Four Xencor Inc directors sold shares totaling $290K on June 15, 2026, all at $12.31 per share. The cluster represents o | Jul 8, 2026 |
| PALI | CLUSTER | neutral | 3/10 | Insider trading cluster at PALISADE BIO shows CEO/CFO John David Finley selling $303K in open-market shares, while Direc | Jul 8, 2026 |
| CTNM | CLUSTER | neutral | 2/10 | Two C-suite insiders at Contineum Therapeutics (CEO and CSO) sold a combined $132K in open-market sales over a 7-day win | Jul 8, 2026 |
| XERS | CLUSTER | bearish | 4/10 | Three Xeris Biopharma insiders (C-suite/top officers) sold a total of ~$1.0M in stock over a 7-day window ending July 6, | Jul 8, 2026 |
| VRTX | CLUSTER | neutral | 2/10 | Three Vertex EVPs sold a total of $1.49M in stock over a one-week period ending July 2, 2026, representing less than 0.0 | Jul 8, 2026 |
| QURE | CLUSTER | bearish | 5/10 | Three insiders at uniQure (QURE), including the CEO and Chief Medical Officer, sold a combined $1.67M in stock within a | Jul 8, 2026 |
| CYTK | CLUSTER | neutral | 2/10 | Four CYTK insiders (CEO, CFO, CCO, EVP R&D) sold a total of $2.32M in shares over a one-week window, but this represents | Jul 8, 2026 |
| KYMR | CLUSTER | bearish | 5/10 | CEO Nello Mainolfi sold $5.95M of KYMR stock at ~$119/share on July 7, 2026, following derivative exercises. CFO Bruce J | Jul 7, 2026 |
| IMNM | CLUSTER | neutral | 4/10 | Two insiders at Immunome, Director Barchas and CMO Lechleider, collectively sold ~$6.0M of stock over the past week, wit | Jul 7, 2026 |
| ADPT | CLUSTER | bearish | 6/10 | Five insiders at Adaptive Biotechnologies, including the Chief Scientific Officer and two Chief Commercial Officers, sol | Jul 7, 2026 |
| STTK | CLUSTER | neutral | 3/10 | Two STTK insiders (Chief Medical Officer and Chief Technical Officer) sold a combined $213K in open-market sales over a | Jul 7, 2026 |
| IMNM | CLUSTER | neutral | 2/10 | Two insiders at Immunome (CMO and a director) sold shares totaling $2.19M in open-market transactions over a 7-day windo | Jul 7, 2026 |
| GLUE | CLUSTER | neutral | 2/10 | Multiple insiders at Monte Rosa Therapeutics (GLUE) sold shares totaling ~$494K over a one-week window, but the aggregat | Jul 7, 2026 |
| SION | CLUSTER | bearish | 5/10 | Three Sionna Therapeutics insiders sold a combined $10.99M in shares over a 7-day window, including two directors who ea | Jul 7, 2026 |
| UTHR | CLUSTER | neutral | 2/10 | CEO Martine Rothblatt and EVP General Counsel Paul Mahon sold a combined ~$8.5M in open-market shares over a 7-day windo | Jul 7, 2026 |
| NUVL | CLUSTER | neutral | 3/10 | Two C-suite executives at Nuvalent (CFO and CDO) sold a combined $2.09M in open-market shares this week, all on the same | Jul 7, 2026 |
| VRTX | CLUSTER | neutral | 2/10 | Two VRTX C-suite executives (CMO and Chief Legal Officer) sold a combined ~$704K in open-market sales over a one-week wi | Jul 7, 2026 |